Mirum Pharmaceuticals, Inc.

NASDAQ:MIRM

Biotechnology

Healthcare
$95.51 +3.81%

+$3.89 today

Market cap
$6.24B
Beta
0.51
P/E (TTM)
-7.8
EPS (TTM)
-$13.57
52W Low $47.89High $114.99

Volume 0.78M

Average 0.95M

Income Statement

Follow revenue through to earnings.

Revenue

$521.31M

FY 2025 · Annual

+54.7% YoY

Operating Income

-$22.14M

FY 2025 · Annual

Net Income

-$23.36M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue19.14M77.06M186.37M336.89M521.31M
Cost of Revenue1.9M12.37M47.04M81.64M100.58M
Gross Profit17.24M64.69M139.34M255.25M420.73M
Gross Margin90.1%83.9%74.8%75.8%80.7%
Research & Development131.43M106.84M102.61M140.63M186.18M
Selling, General & Admin59.22M89.07M145.88M202.22M257.03M
Operating Expenses190.65M195.91M248.49M342.85M443.21M
Depreciation & Amortization975K3.24M10.83M23.63M24.24M
EBITDA(65.39M)(122.85M)(136.49M)(48.97M)17.21M
EBITDA Margin-341.7%-159.4%-73.2%-14.5%3.3%
Operating Income(173.41M)(131.22M)(109.15M)(87.61M)(22.14M)
Operating Margin-906.1%-170.3%-58.6%-26.0%-4.2%
Interest Income366K3.86M13.74M13.79M12.73M
Interest Expense17.59M15.98M15.11M14.31M14.39M
Other Income / Expenses89.46M(10.85M)(53.27M)694K709K
Income Before Tax(83.95M)(142.07M)(162.42M)(86.91M)(21.43M)
Pre-Tax Margin-438.7%-184.4%-87.1%-25.8%-4.1%
Income Tax Expense37K(6.41M)991K1.03M1.94M
Net Income(83.99M)(135.67M)(163.42M)(87.94M)(23.36M)
Net Margin-438.9%-176.0%-87.7%-26.1%-4.5%
EPS (Basic)(2.77)(4.01)(4.00)(1.85)(0.47)
EPS (Diluted)(2.77)(4.02)(4.00)(1.85)(0.47)
Weighted Avg Shares30.32M33.84M40.89M47.52M50.2M
Weighted Avg Shares (Diluted)30.32M33.98M40.89M47.52M50.2M

MIRM Earnings Waterfall · TTM

NASDAQ:MIRM · Revenue to Net Income

Key Ratios

EPS$-14.56
Gross Margin81.6%
Net Margin-133.5%
P/E Ratio41.4
P/S Ratio33.5

Analysis

$618.1M of revenue converted into -$860.2M of net income for the selected period. Gross margin is 81.6% and net margin is -133.5%, showing how much revenue survives after costs and taxes. EPS is $-14.56, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 13, 2026
8-KCurrent reportNov 10, 2026
4Statement of changes in beneficial ownershipNov 4, 2026
10-QQuarterly reportNov 3, 2026
8-KCurrent reportNov 3, 2026

How much revenue does MIRM generate?

Mirum Pharmaceuticals, Inc. (MIRM) reported $521.31M of revenue in fiscal 2025.

Is MIRM profitable?

Mirum Pharmaceuticals, Inc. (MIRM) reported -$23.36M of net income, with a net margin of -4.5%.